Stryker (SYK) EBITDA Margin: History & Chart

Stryker Corporation(SYK)

Medical - Devices · Portage, MI

$275.12-5.01 (-1.79%)

Delayed quote: Sep 18, 2026, 4:00 PM EDT

About Stryker Corporation

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

Portage, MI

56,000 employees

www.stryker.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Kevin A. Lobo

View full financials

SYK EBITDA Margin Metrics

EBITDA MARGIN

24.22%

EBITDA MARGIN AVG TTM

26.74%

EBITDA MARGIN AVG 3Y

26.64%

EBITDA MARGIN AVG 5Y

26.41%

EBITDA MARGIN AVG 10Y

26.81%

EBITDA MARGIN AVG 15Y

25.73%

EBITDA MARGIN AVG 20Y

26.56%

CURRENT VS TTM AVG

-9.44%

CURRENT VS 3Y AVG

-9.07%

CURRENT VS 5Y AVG

-8.30%

CURRENT VS 10Y AVG

-9.67%

CURRENT VS 15Y AVG

-5.87%

CURRENT VS 20Y AVG

-8.80%

NAME	MARKET CAP	EBITDA MARGIN	TTM	3Y	5Y
Stryker Corporation (SYK)	$105.47B	24.22%	26.74%	26.64%	26.41%
McKesson Corporation (MCK)vs ›	$102.40B	1.78%	1.58%	1.64%	1.66%
Sanofi (SNY)vs ›	$102.00B	32.70%	28.59%	29.32%	32.36%
GSK plc (GSK)vs ›	$100.62B	32.61%	26.78%	28.16%	28.64%
CVS Health Corp. (CVS)vs ›	$113.35B	3.73%	3.63%	4.02%	4.83%
Medtronic plc (MDT)vs ›	$117.93B	25.92%	26.11%	25.62%	25.51%
HCA Healthcare, Inc. (HCA)vs ›	$92.60B	20.49%	20.06%	19.91%	20.05%
Elevance Health Inc. (ELV)vs ›	$89.12B	4.85%	5.33%	5.81%	6.32%
Bristol-Myers Squibb Company (BMY)vs ›	$128.81B	36.80%	38.33%	39.88%	39.69%
Vertex Pharmaceuticals Incorporated (VRTX)vs ›	$129.02B	41.14%	20.45%	32.86%	36.27%

NAME

MARKET CAP

EBITDA MARGIN

TTM

Stryker Corporation (SYK)

$105.47B

24.22%

26.74%

26.64%

26.41%

McKesson Corporation (MCK)vs ›

$102.40B

1.78%

1.58%

1.64%

1.66%

Sanofi (SNY)vs ›

$102.00B

32.70%

28.59%

29.32%

32.36%

GSK plc (GSK)vs ›

$100.62B

32.61%

26.78%

28.16%

28.64%

CVS Health Corp. (CVS)vs ›

$113.35B

3.73%

3.63%

4.02%

4.83%

Medtronic plc (MDT)vs ›

$117.93B

25.92%

26.11%

25.62%

25.51%

HCA Healthcare, Inc. (HCA)vs ›

$92.60B

20.49%

20.06%

19.91%

20.05%

Elevance Health Inc. (ELV)vs ›

$89.12B

4.85%

5.33%

5.81%

6.32%

Bristol-Myers Squibb Company (BMY)vs ›

$128.81B

36.80%

38.33%

39.88%

39.69%

Vertex Pharmaceuticals Incorporated (VRTX)vs ›

$129.02B

41.14%

20.45%

32.86%

36.27%

EBITDA Margin FAQ

What is the EBITDA margin for Stryker Corporation (SYK)?

The EBITDA margin for SYK stock is 24.22%.

Is Stryker Corporation's EBITDA margin high or low?

The EBITDA margin of 24.22% is in line with its 5-year average of 26.41%, around the middle of its 5-year range (20.53%–31.75%).

What is the TTM average EBITDA margin for Stryker Corporation (SYK)?

The TTM average EBITDA margin for SYK stock is 26.74%.

What is the 3Y average EBITDA margin for Stryker Corporation (SYK)?

The 3Y average EBITDA margin for SYK stock is 26.64%.

What is the 5Y average EBITDA margin for Stryker Corporation (SYK)?

The 5Y average EBITDA margin for SYK stock is 26.41%.

What is the 10Y average EBITDA margin for Stryker Corporation (SYK)?

The 10Y average EBITDA margin for SYK stock is 26.81%.

What is the 15Y average EBITDA margin for Stryker Corporation (SYK)?

The 15Y average EBITDA margin for SYK stock is 25.73%.

What is the 20Y average EBITDA margin for Stryker Corporation (SYK)?

The 20Y average EBITDA margin for SYK stock is 26.56%.

DATE	EBITDA MARGIN
2026-06-30	29.67%
2026-03-31	20.53%
2025-12-31	31.75%
2025-09-30	24.25%
2025-06-30	27.52%
2025-03-31	24.74%
2024-12-31	29.94%
2024-09-30	26.87%
2024-06-30	26.12%
2024-03-31	24.09%
2023-12-31	28.80%
2023-09-30	25.52%
2023-06-30	26.48%
2023-03-31	23.34%
2022-12-31	27.84%
2022-09-30	24.54%
2022-06-30	25.80%
2022-03-31	24.00%
2021-12-31	28.25%
2021-09-30	27.19%
2021-06-30	27.43%
2021-03-31	25.40%
2020-12-31	30.95%
2020-09-30	29.89%
2020-06-30	14.51%
2020-03-31	25.42%
2019-12-31	29.82%
2019-09-30	26.37%
2019-06-30	27.92%
2019-03-31	26.22%
2018-12-31	28.77%
2018-09-30	27.08%
2018-06-30	27.97%
2018-03-31	26.91%
2017-12-31	26.85%
2017-09-30	26.48%
2017-06-30	26.89%
2017-03-31	26.16%
2016-12-31	27.65%
2016-09-30	27.00%
2016-06-30	22.71%
2016-03-31	24.89%
2015-12-31	27.85%
2015-09-30	19.79%
2015-06-30	19.65%
2015-03-31	19.13%
2014-12-31	21.54%
2014-09-30	22.90%
2014-06-30	16.97%
2014-03-31	9.63%
2013-12-31	20.75%
2013-09-30	10.51%
2013-06-30	16.68%
2013-03-31	20.82%
2012-12-31	21.05%
2012-09-30	27.78%
2012-06-30	26.88%
2012-03-31	27.72%
2011-12-31	24.38%
2011-09-30	27.94%
2011-06-30	25.47%
2011-03-31	26.72%
2010-12-31	24.95%
2010-09-30	32.34%
2010-06-30	31.09%
2010-03-31	30.33%
2009-12-31	33.74%
2009-09-30	24.68%
2009-06-30	29.49%
2009-03-31	29.41%
2008-12-31	26.97%
2008-09-30	27.93%
2008-06-30	29.17%
2008-03-31	29.48%
2007-12-31	27.65%
2007-09-30	52.49%
2007-06-30	28.91%
2007-03-31	27.82%
2006-12-31	26.88%
2006-09-30	26.21%
2006-06-30	28.15%
2006-03-31	22.70%
2005-12-31	26.22%
2005-09-30	25.80%
2005-06-30	27.16%
2005-03-31	26.62%
2004-12-31	25.89%
2004-09-30	13.30%
2004-06-30	26.95%
2004-03-31	24.56%
2003-12-31	27.12%
2003-09-30	24.19%
2003-06-30	24.12%
2003-03-31	24.69%
2002-12-31	23.18%
2002-09-30	24.96%

DATE

EBITDA MARGIN

2026-06-30

29.67%

2026-03-31

20.53%

2025-12-31

31.75%

2025-09-30

24.25%

2025-06-30

27.52%

2025-03-31

24.74%

2024-12-31

29.94%

2024-09-30

26.87%

2024-06-30

26.12%

2024-03-31

24.09%

2023-12-31

28.80%

2023-09-30

25.52%

2023-06-30

26.48%

2023-03-31

23.34%

2022-12-31

27.84%

2022-09-30

24.54%

2022-06-30

25.80%

2022-03-31

24.00%

2021-12-31

28.25%

2021-09-30

27.19%

2021-06-30

27.43%

2021-03-31

25.40%

2020-12-31

30.95%

2020-09-30

29.89%

2020-06-30

14.51%

2020-03-31

25.42%

2019-12-31

29.82%

2019-09-30

26.37%

2019-06-30

27.92%

2019-03-31

26.22%

2018-12-31

28.77%

2018-09-30

27.08%

2018-06-30

27.97%

2018-03-31

26.91%

2017-12-31

26.85%

2017-09-30

26.48%

2017-06-30

26.89%

2017-03-31

26.16%

2016-12-31

27.65%

2016-09-30

27.00%

2016-06-30

22.71%

2016-03-31

24.89%

2015-12-31

27.85%

2015-09-30

19.79%

2015-06-30

19.65%

2015-03-31

19.13%

2014-12-31

21.54%

2014-09-30

22.90%

2014-06-30

16.97%

2014-03-31

9.63%

2013-12-31

20.75%

2013-09-30

10.51%

2013-06-30

16.68%

2013-03-31

20.82%

2012-12-31

21.05%

2012-09-30

27.78%

2012-06-30

26.88%

2012-03-31

27.72%

2011-12-31

24.38%

2011-09-30

27.94%

2011-06-30

25.47%

2011-03-31

26.72%

2010-12-31

24.95%

2010-09-30

32.34%

2010-06-30

31.09%

2010-03-31

30.33%

2009-12-31

33.74%

2009-09-30

24.68%

2009-06-30

29.49%

2009-03-31

29.41%

2008-12-31

26.97%

2008-09-30

27.93%

2008-06-30

29.17%

2008-03-31

29.48%

2007-12-31

27.65%

2007-09-30

52.49%

2007-06-30

28.91%

2007-03-31

27.82%

2006-12-31

26.88%

2006-09-30

26.21%

2006-06-30

28.15%

2006-03-31

22.70%

2005-12-31

26.22%

2005-09-30

25.80%

2005-06-30

27.16%

2005-03-31

26.62%

2004-12-31

25.89%

2004-09-30

13.30%

2004-06-30

26.95%

2004-03-31

24.56%

2003-12-31

27.12%

2003-09-30

24.19%

2003-06-30

24.12%

2003-03-31

24.69%

2002-12-31

23.18%

2002-09-30

24.96%

EBITDA Margin: 24.22%

SYK EBITDA Margin

SYK Average EBITDA Margin Chart

SYK Current vs Average EBITDA Margin Chart

SYK EBITDA Margin Metrics

SYK Competitors' EBITDA Margin

Margin Comparison

EBITDA Margin Formula & Definition

EBITDA Margin FAQ

SYK EBITDA Margin History

Related Metrics